HealthCor Management’s Collegium Pharmaceutical COLL Stock Holding History

HealthCor Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,426,300	Closed	-$22.2M	–	38
2016 Q4	$22.2M	Buy	1,426,300 +26,300	+2%	+$437K	1.25%	25
2016 Q3	$27M	Buy	1,400,000 +75,000	+6%	+$891K	1.64%	21
2016 Q2	$15.7M	Buy	1,325,000 +100,000	+8%	+$1.65M	0.86%	32
2016 Q1	$22.2M	Buy	1,225,000 +200,000	+20%	+$3.64M	1.26%	25
2015 Q4	$28.2M	Buy	1,025,000 +75,000	+8%	+$1.58M	1.71%	22
2015 Q3	$21M	Buy	950,000 +476,336	+101%	+$8.61M	1.18%	25
2015 Q2	$8.45M	Buy	+473,664	New	+$8.19M	0.43%	39

Other funds holding COLL

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HealthCor Management's COLL Position: Q1 2017 in Review

HealthCor Management sold out of Collegium Pharmaceutical (COLL) in Q1 2017, closing a stake of 1,426,300 shares — an estimated $22.2M sold.

HealthCor Management first reported a position in COLL in Q2 2015 and held it in 7 quarters. The position peaked at $28.2M in Q4 2015. 83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

HealthCor Management reported no remaining Collegium Pharmaceutical position as of Q1 2017 after selling out during the quarter.
HealthCor Management sold 1,426,300 Collegium Pharmaceutical shares in Q1 2017, an estimated $22.2M.
HealthCor Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 7 quarters.
HealthCor Management's Collegium Pharmaceutical position peaked at $28.2M in Q4 2015.
83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on HealthCor Management's 13F filing for Q1 2017, filed 15 May 2017.